News
RSMDF
22.48
NaN%
--
*ResMed Backs FY27 Adj EPS $12-Adj EPS $12.25 >RMD
Dow Jones · 8h ago
*ResMed Backs FY27 Rev $5.75B-$5.85B >RMD
Dow Jones · 8h ago
*ResMed Sees FY27 Core Constant Currency Rev Growth of 5 % - 7%
Dow Jones · 8h ago
Press Release: Resmed Inc. Announces Results for -2-
Dow Jones · 9h ago
*ResMed 1Q Adj EPS $2.91 >RMD
Dow Jones · 9h ago
*ResMed 1Q Rev $1.41B >RMD
Dow Jones · 9h ago
Press Release: Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027
Dow Jones · 9h ago
*ResMed 1Q EPS $2.92 >RMD
Dow Jones · 9h ago
*ResMed 1Q Net $418.4M >RMD
Dow Jones · 9h ago
Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026
Barchart · 10/01 15:05
Dividend Announcements: August 1-7, 2026
Seeking Alpha · 08/16 13:37
Resmed Announces Agreement to Sell MatrixCare Business
Barchart · 07/07 15:30
ResMed: GLP-1 Threats Are Overstated
Seeking Alpha · 06/11 11:05
Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?
Seeking Alpha · 05/11 20:30
10 Dividend Growth Stocks: May 2025
Seeking Alpha · 05/09 13:00
ResMed Inc. Reports Quarterly Results for the Period Ended March 31, 2026
Press release · 05/02 07:30
ResMed expects FY 2026 gross margin of 62%-63% as it plans $175M+ Q4 buybacks and targets June 1 close for $340M Noctrix deal
Seeking Alpha · 05/01 00:22
I Shared 42 Sell Ratings In 2019. Here Is How They Have Performed Long-Term.
Seeking Alpha · 04/07 16:24
Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026
Barchart · 04/01 15:05
ResMed: Waiting For The Next Catalyst, Initiating With Hold Rating
Seeking Alpha · 03/16 16:45
More
Webull provides a variety of real-time RSMDF stock news. You can receive the latest news about Resmed through multiple platforms. This information may help you make smarter investment decisions.
About RSMDF
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.